Our Leadership Team
Chief Executive Officer
Dr. Toni Rinow holds the position of Chief Executive Officer at Pivot Pharma. She led healthcare
organizations as General Manager at global nuclear medicine leader Jubilant Draximage and as Chief
Operating Officer at Isologic Innovative Radiopharmaceuticals. Her professional career includes
leadership roles in both public and private pharmaceutical and healthcare organizations, where she
spearheaded acquisitions across Canada, Latin America, and India and supported the transition of two biotechnology companies to an initial public offering at the Toronto Stock Exchange.
Toni has successfully facilitated the negotiation of international corporate alliances valued over $100M and overseen a life science investment portfolio with $400M under management.
In addition to her Masters of Business Administration degree (MBA) from McGill University, she holds a doctorate in physical chemistry from the Université de Montréal (Ph.D), and a chemical engineering
degree from the European Higher Institute of Chemistry in Strasbourg, France. Dr. Rinow believes in
giving back to the community and sits on the Board of Directors in several non-for profit organizations.
President and Director
Russell is an entrepreneur and financial professional focused on private and public mining/exploration and corporate advisory. With over 19 years of corporate finance, investment and business development experience, Russell is currently President of Pivot Pharmaceuticals.
Prior to current activities, Russell held senior positions and advisory roles with financial institutions including RBC Capital Markets, Scotia Capital, Orion Securities, Blackmont, Lawrence and Company, where Russell helped raise over a billion dollars for junior and mid-tier companies. Russell is also a co-founder and part owner of Echelon Wealth Partners, a large Canadian investment dealer.
After leaving Bay Street, Russell held an executive position and board appointment with Cayden Resources, acquired by Agnico Eagle in 2014. As a SVP with Cayden Resources and board member, Russell was integral in the marketing, financing, development and ultimate sale of Cayden for CAD$205 million to Agnico Eagle.
Russell holds a MBA from the Richard Ivey School of Business, a Master of Arts degree in Economics from the University of Victoria and a Bachelor of Arts degree in Economics from Queens University. Russell was also a PhD candidate at McGill University in Econometrics.
Chief Operating Officer
Chris Lucky is the Chief Operating Office of Pivot Pharmaceuticals. Mr. Lucky is a seasoned
business leader with over 20 years’ experience leading and managing complex businesses. He
has a proven track record of delivering year over year improvements by designing and
implementing scaleable and sustainable business solutions.
His experience spans across multiple industries including retail, manufacturing and distribution
with a deep understanding of organizational effectiveness and building efficient operational
models that delivers consistent results. He’s held roles at CannTrust as Vice President, Supply
Chain & Manufacturing, Cardinal Health as Vice President, Distributions, Loblaw Companies as
Vice President, Supply Chain, & Hudson Bay Company as Director Supply Chain.
He is an inclusive leader that is transparent and strives on building lasting relationships, leading
with passion and an attitude to win. He holds an MBA from Ivey School of Business and a BBA in
accounting and financial management.
Wolfgang Renz, MD, PHD
Chief Medical Officer, Regional Manager – Europe and Director
Wolfgang Renz is President of International Business at Physicians Interactive. Formerly, he served as Corporate Vice President of Business Model & Healthcare Innovation at Boehringer Ingelheim, one of the world’s largest pharmaceutical companies. For over a decade, he has been involved in developing medicines and technology to help people lead healthier, more productive lives. At Boehringer Ingelheim, he led a team of specialists to find, test, and develop the disruptive technologies that will shape the way health care will be delivered in the future. In addition, he also serves as Adjunct Professor of Surgery at McGill University’s Faculty of Medicine in Montreal, Canada. Prof. Renz holds a medical degree and a PhD from Freiburg University and is board certified in Germany in emergency medicine.
Dr. Joseph Borovsky, PHD
Lead Director & Executive Vice President, Product Development
Dr. Borovsky is an experienced CEO and entrepreneur with broad-based success in leading major corporate research and development as well as innovative technology startups, P & L operations, sales, and marketing. Formerly the director of R & D for Mead Corporation, Dr. Borovsky received his Bachelor of Science degree in Chemistry from the University of California at Los Angeles, and his Ph.D. in Physical Organic Chemistry from the University of Massachusetts at Amherst. He also completed a year of post- doctoral research in Medicinal Chemistry at Washington State University College of Pharmacy, Pullman, WA, and was a Research Fellow in Synthetic Organic Chemistry at Harvard University in Cambridge, Massachusetts.
Moira Ong, CPA, CA
Chief Financial Officer
Moira Ong is a Chartered Professional Accountant with over 16 years of experience in accounting and consulting. Moira was the Chief Financial Officer of Neurokine Pharmaceuticals Inc. and was an officer in the finance capacity of Merus Labs International Inc. from March 2010 through December 2012. In addition to holding her Chartered Professional Accountant (CPA, CA) designation, Moira is also a Chartered Financial Analyst (CFA).